Posted on 5/9/18
CURE Media Group Welcomes the Bonnie J. Addario Lung Cancer Foundation to Its Strategic Alliance Partnership Program
CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, expands the Strategic Alliance Partnership (SAP) . . .
Posted on 5/8/18
Johnson & Johnson Looks To Change The Scope Of Depression Treatment
Johnson & Johnson announced mixed results for patients with treatment-resistant depression.While only one of the two studies met the primary endpoint, both studies were still highly . . .
Posted on 5/8/18
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHESTERBROOK, Pa., May 08, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company . . .
Posted on 5/7/18
Recro Pharma Announces Receipt of Issue Notifications for Three New Patents for IV Meloxicam
MALVERN, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other . . .
Posted on 5/7/18
Teva: A Better Entry Point Post-Results
Unjustified Sell-down Post-Q1 2018 Results AnnouncementTeva Pharmaceutical (TEVA) reported market-beating Q1 2018 results before the market opened on Thursday. While its share price expectedly gained as . . .
Posted on 5/7/18
This Biotech Stock Could Be Like Buying Celgene in 2006
You can't turn back the clock and buy Celgene 12 years ago when it first won approval for its multibillion-dollar blockbuster multiple myeloma drug Revlimid, but . . .
Posted on 5/4/18
Teva Pharmaceutical Industries Limited 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2018 Q1 earnings call. 134READ FULL ARTICLE HERE
Posted on 5/4/18
Strongbridge Biopharma plc Announces New Employment Inducement Awards
DUBLIN, Ireland and TREVOSE, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization . . .
Posted on 5/4/18
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
CAMBRIDGE, Mass. & KENILWORTH N.J.--(BUSINESS WIRE)--Moderna Therapeutics and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced an expansion of their 2016 . . .
Posted on 5/3/18
Trevena Reports First Quarter 2018 Financial Results
CHESTERBROOK, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced financial results for the quarter ended March 31, 2018 and provided an update . . .
Posted on 5/3/18
Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)
This big drugmaker faces challenges in the future for its top-selling product, a highly successful immunology drug. But it also has one of the fastest-growing cancer . . .
Posted on 5/3/18
Here's What Pfizer's Saying About 2018
Pfizer Inc.'s (NYSE:PFE) first-quarter 2018 earnings results this week included bright spots, such as ongoing growth in oncology and biosimilars, and disappointments, including sliding sales for . . .
Posted on 5/3/18
Hackensack Meridian Health Joins NJII's Cell and Gene Therapy Development Center
The New Jersey Innovation Institute (NJII), an NJIT Corporation, has announced that Hackensack Meridian Health has joined its Cell and Gene Therapy Development Center to access . . .
Posted on 5/2/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies . . .
Posted on 5/2/18
Marinus Pharmaceuticals Provides Business Update
RADNOR, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 5/2/18
D.R. Horton’s New Jersey Division Opens Whispering Hills in Barnegat
BARNEGAT, N.J., May 02, 2018 (GLOBE NEWSWIRE) -- D.R. Horton’s New Jersey division is pleased to announce the opening of its Whispering Hills community in Barnegat, . . .
Posted on 5/2/18
Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results
RADNOR, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 5/2/18
Insmed Reports First Quarter 2018 Financial Results and Provides Business Update
BRIDGEWATER, N.J., May 02, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today . . .
Posted on 5/2/18
Johnson & Johnson To Acquire BeneVir Biopharm
Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech has agreed to acquireprivately held BeneVir Biopharm for an undisclosed sum.The Rockville, MD-based biotech develops oncolytic viral immunotherapies to . . .
Posted on 5/2/18
Merck Company Inc. (MRK) Q1 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Merck & Company, Inc. (NYSE:MRK)Q1 2018 Earnings Conference CallMay 1, 2018, 8:00 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning. My name . . .
Posted on 5/2/18
3 Numbers That Should Grab Your Attention in Merck's Q1 Earnings
Most of the headlines you'll see about Merck's (NYSE:MRK) first-quarter results focus on the company's better-than-expected earnings and lower-than-expected revenue.It's true that Merck did report Q1 . . .
Posted on 5/2/18
Pfizer Q1 Earnings: What You Need to Know
It seems every time Pfizer (NYSE:PFE) reports its quarterly results, good news is accompanied by bad news. That was the case yet again when the big . . .
Posted on 5/2/18
Pfizer, Inc. (PFE) Q1 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Pfizer, Inc. (NYSE:PFE)Q1 2018 Earnings Conference CallMay 1, 2018, 10:00 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood day everyone and welcome to . . .
Posted on 5/2/18
Onconova Therapeutics Closes $28.75M Offering
NEWTOWN, Pa., May 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug . . .
Posted on 5/2/18
Trevena and Jiangsu Nhwa Pharmaceutical Co. Ltd Announce License Agreement for Oliceridine in China
CHESTERBROOK, Pa. and XUZHOU, China, May 01, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) and Jiangsu Nhwa Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange:002262) announced today that . . .

